We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Abbott FDA-Cleared Blood Test Evaluates Need for CT scans in Patients with Head Injury
Abbott FDA-Cleared Blood Test Evaluates Need for CT scans in Patients with Head Injury
Abbott’s newly FDA-cleared blood test is the first commercially available diagnostic that assesses whether a patient with a mild traumatic brain injury (mTBI) — commonly known as a concussion — needs further evaluation with a computed tomography (CT) scan.